Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegillaline fumarate versus sufentanil for postoperative analgesia and gastrointestinal recovery after laparoscopic gynecologic surgery in elderly patients
ChiCTR2600135125Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Postoperative gastrointestinal dysfunction (POGD) comparing Experimental group (tegillaline fumarate) with Control group (sufentanil) (2 arms). Primary endpoint: I-FEED score. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
tegileridinesufentanil
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on ChiCTR2600135125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135125.